MCM7 and glioma: MCMs expression was significantly up-regulated in variety of tumors and the expression of MCM7 has been reported as an independent risk factor for relapse-free survival and correlated with poor outcome in patients with colorectal cancer, oesophageal squamous cell carcinoma and glioma [55–57].